CD4 and cancer: The levels of peripheral blood T lymphocyte subsets (CD3+CD4+, CD3+CD8+, and CD4+/CD8+) in patients with malignant tumor before and after chemotherapy can be detected to evaluate the immune function of patients and evaluate the prognosis.